MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.089
+0.002 (+2.30%)
As of 1:10PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.087
Open0.094
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.085 - 0.094
52 Week Range0.060 - 0.190
Volume4,270,901
Avg. Volume7,588,980
Market Cap292.965M
Beta (3Y Monthly)-1.81
PE Ratio (TTM)N/A
EPS (TTM)-0.087
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire4 hours ago

    Medical Marijuana, Inc. CEO to Speak, Subsidiary HempMeds® to Exhibit at Cannabis World Congress in Boston

    SAN DIEGO, Oct. 16, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at the Cannabis World Congress and Business Expo, taking place in Boston from Oct. 17-20. Medical Marijuana, Inc. CEO Dr. Stuart Titus will also be speaking on an expert panel at the conference discussing the evidence for medical cannabis. "As cannabis research continues to flourish in the United States and throughout the world, I am proud to be at the forefront of this conversation and help people understand the many intricate facets of the industry," Titus said.

  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Speaks at Fourth International Congress of Neuroscience in São Paulo, Brazil
    PR Newswireyesterday

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Speaks at Fourth International Congress of Neuroscience in São Paulo, Brazil

    SAN DIEGO, Oct. 15, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that an executive from its subsidiary HempMeds® Brasil spoke on the benefits of cannabidiol (CBD) hemp oil at the Fourth International Congress of Neuroscience at the Albert Einstein Hospital in São Paulo, Brazil on Oct. 5, 2018. "Participating in the International Congress of Neuroscience allows us to connect with medical professionals throughout Brazil and offer important education on the benefits of CBD," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

  • Benzinga4 days ago

    Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

    It was another busy week for the cannabis industry, with Aurora Cannabis Inc  (OTC: ACBFF ) applying to list on the New York Stock Exchange, tobacco giant Altria Group Inc.  (NYSE: MO ) reportedly showing  ...

  • PR Newswire5 days ago

    Medical Marijuana, Inc. CEO to Speak at CBD Outlook Conference on Humulus-Derived CBD

    SAN DIEGO , Oct. 11, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , announced today that the company's Chief Executive ...

  • PR Newswire6 days ago

    Medical Marijuana, Inc. Launches Dixie Botanicals Canada®

    Innovative Lifestyle Brand Introduces CBD-only Products to the Canadian Market SAN DIEGO , Oct. 10, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company ...

  • PR Newswire7 days ago

    Medical Marijuana, Inc. Announces Q3 2018 as the Largest Sales Bookings Quarter in Company History

    SAN DIEGO , Oct. 9, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the company and its subsidiary ...

  • Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Single Serving Size Sample Packs
    PR Newswire8 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Single Serving Size Sample Packs

    SAN DIEGO , Oct. 8, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that its subsidiary Kannaway® , the ...

  • Is Medical Marijuana Inc. a Buy?
    Motley Fool10 days ago

    Is Medical Marijuana Inc. a Buy?

    Medical Marijuana has been a disappointing investment to date, but things might finally be looking up for the company. Here's why.

  • PR Newswire12 days ago

    Medical Marijuana, Inc. Launches Real Scientific Canada™ Throughout Canada

    SAN DIEGO, Oct. 4, 2018 /PRNewswire/ -- Medical Marijuana Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, is pleased to announce that its brand, Real Scientific Canada™ will be launching across Canada, through Canadian extraction and formulation company Salvation Botanicals, Ltd. ("Salvation"). On October 17, Real Scientific Canada™ will be introducing several of its cannabis products, including internationally-recognized Real Scientific Hemp Oil™ (RSHO™).

  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Release of Full-Spectrum 5,000 mg Liquid CBD Hemp Oil
    PR Newswire14 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Release of Full-Spectrum 5,000 mg Liquid CBD Hemp Oil

    SAN DIEGO, Oct. 2, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil has released a new full-spectrum 5,000 mg cannabidiol (CBD) hemp oil liquid for the rapidly-expanding Brazil market. "We are very excited to announce this new CBD hemp oil product in Brazil," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus.

  • PR Newswire15 days ago

    National Football Champion Joins Medical Marijuana, Inc. Subsidiary Kannaway® Sports Team

    SAN DIEGO, Oct. 1, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that former Dallas Cowboys offensive lineman and Super Bowl champion Derek Kennard has become a spokesperson for its subsidiary Kannaway® to help spread awareness on the benefits of cannabidiol (CBD) for athletes and active consumers. "We look forward to working with Derek Kennard to continue our goal of spreading awareness and increasing public education about the health benefits of CBD," said Kannaway® CEO Blake Schroeder.

  • Benzinga18 days ago

    Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week

    Green Market Report CEO Debra Borchardt told Benzinga the DEA's move was “a step in the right direction.” However, she noted “the DEA stressed that it basically only applied to this specific drug. Over the last five trading days, the Horizons Marijuana Life Sciences Index ETF (OTC: HMLSF) (TSE:HMMJ) tumbled 2.8 percent, while the ETFMG Alternative Harvest ETF (NYSE: MJ) gained 1.5 percent.

  • PR Newswire19 days ago

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Host Q&A Event at Imperial Beach Pet Stores

    SAN DIEGO, Sept. 27, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health will be hosting Q&A events at two of IB Pet's Southern California locations. The first will be at IB Pet's Imperial Beach storefront on Saturday, Sept. 29 at 10:00 a.m. and a second Q&A at its Rancho San Diego storefront at 2:00 p.m. During the events, attendees will have the chance to ask questions and hear from Phyto Animal Health Chief Executive Officer Ian Quinn about the benefits of cannabidiol (CBD) for animals.

  • PR Newswire19 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Launches New 50mg Active Relief Roll-On Product at 2018 Cannabis World Congress Los Angeles

    SAN DIEGO , Sept. 27, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , subsidiary HempMeds® announced today that it will ...

  • Benzinga20 days ago

    High Times Buys DOPE Magazine For $11M: Here's Why And What It Means For The Cannabis Industry

    In the latest move toward consolidation in the industry, High Times announced Wednesday it has acquired DOPE Media in a split of cash and stock transaction valued at $11.2 million. "The acquisition of Dope Media will be a key building block as we continue on our mission to create brand-safe inventory for brands of all sizes," High Times CEO Adam Levin told Benzinga.

  • Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at Cannabis World Congress and Business Expo in Los Angeles
    PR Newswire20 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® to Exhibit at Cannabis World Congress and Business Expo in Los Angeles

    SAN DIEGO, Sept. 26, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will be exhibiting its line of cannabidiol (CBD) hemp oil products at the Cannabis World Congress and Business Expo, taking place in Los Angeles from September 27-29. "As CBD continues to gain significant attention in the health and wellness community, we are proud to be at an event that is dedicated to spreading awareness of its benefits," said HempMeds® President Todd Morrow. The Cannabis World Congress and Business Expo is held three times a year in the largest media, financial and business markets: Los Angeles, New York and Boston.

  • Medical Marijuana, Inc. Announces Todd Morrow as New President of Subsidiary HempMeds®
    PR Newswire21 days ago

    Medical Marijuana, Inc. Announces Todd Morrow as New President of Subsidiary HempMeds®

    SAN DIEGO, Sept. 25, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced Todd Morrow as the new President of the Company's subsidiary HempMeds®. In his new role, Morrow will oversee all facets of the HempMeds® organization, focusing on continued growth and development of the company's premier brand, Real Scientific Hemp Oil. Morrow, who has more than 19 years of experience in product development, merchandising and marketing, plans to launch new product offerings and help build and maintain product registrations globally for the company.

  • TheStreet.com26 days ago

    Cannabis Could Disrupt the Lucrative Market for Painkillers

    Experts are zeroing in on cannabis as a potential disruptor to the multibillion-dollar prescription-opioid market. According to the 2015 National Survey on Drug Use and Health, 37.8% of the United States adult population was prescribed opioid drugs in 2015. The extremely high rate of prescriptions in the United States as well as internationally has led Grandview Research to forecast the global opioids market to total $34.96 billion by 2025.

  • PR Newswire26 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes New Brand Ambassador to Achieve Crown Ambassador Elite Rank

    SAN DIEGO , Sept. 20, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC:MJNA), announced today that its subsidiary Kannaway ®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical ...

  • PR Newswire27 days ago

    The Wall Street Journal Features Medical Marijuana, Inc. Subsidiary Kannaway® Discussing the Popularity of CBD

    SAN DIEGO, Sept. 19, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® has garnered international news coverage in leading daily news publication, The Wall Street Journal. A September 12, 2018 article in The Wall Street Journal website titled "Cannabis Comes to Your Coffee and Candy—But Is It Legal?" discusses the recent popularity of cannabidiol (CBD) products around the world, highlighting the inclusion of CBD in many new food and beverage products and the complex legality of CBD in the United States. "Kannaway is honored to be included of this article and the ongoing conversation surrounding CBD and its health and therapeutic benefits," said Kannaway® CEO Blake Schroeder.

  • PR Newswire28 days ago

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Exhibit and Speak at CBD Expo West

    SAN DIEGO, Sept. 18, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health will be exhibiting its products and speaking on a featured expert panel at CBD Expo West in Anaheim, CA on September 21-22. CBD Expo West, hosted at the Marriott Anaheim, is the first and only show dedicated entirely to CBD. The event will feature more than 60 exhibitors, along with a large lineup of presentations and panel discussions featuring experts in the production, distribution and sale of CBD products.

  • Marijuana Use Is Suddenly "Booming" With This Group of People
    Motley Foollast month

    Marijuana Use Is Suddenly "Booming" With This Group of People

    This is what you call "turning over a new leaf."

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Announces Sponsorship of Last-Ever Run 4 Hope Festival & 5K

    SAN DIEGO, Sept. 14, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® is sponsoring the seventh and last-ever annual Run 4 Hope Festival and 5K in Coppell, TX on Saturday, September 15, 2018. Run 4 Hope is in memory of Harper Elle Howard, the little girl with CDKL5 epilepsy who helped bring medical marijuana to Latin America, and lost her battle to a CDKL5 disorder on Jan. 8, 2016. According to the International Foundation for CDKL5 Research, there are fewer than 1,000 diagnosed cases of this rare, life-threatening genetic disorder worldwide, with one in 22 people diagnosed with epilepsy.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes Recent Brand Ambassadors to Achieve Crown Ambassador Elite Rank

    SAN DIEGO , Sept. 13, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary Kannaway, LLC , the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical ...

  • PR Newswirelast month

    Medical Marijuana, Inc. Signs Agreement with Salvation Botanicals, Ltd. to Bring Company's Expertise to Canada

    SAN DIEGO, Sept. 12, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it has signed a contract with Canadian extraction and formulation company Salvation Botanicals, Ltd. ("Salvation") to manufacture products in Canada. According to a recent report by Deloitte, Canadians are expected to spend up to $7 billion on cannabis products in 2019, exceeding Canadian liquor sales projected to be $5 billion. Deloitte also projects that overall cannabis consumption is set to increase by up to 35 percent. "We're thrilled to sign this agreement and bring our expertise into the Canadian market, especially with a respected partner such as Salvation Botanicals," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.